Lupus & antiphospholipid syndrome
Diagnostic, research, and real-life effect of the 2023 EULAR−ACR classification criteria for antiphospholipid syndrome
Study context
- Population
- Pregnant individuals with APS (focus on pregnancy-related aspects)
Main finding
As reported in the abstract
- 2023 ACR-EULAR APS classification criteria improved precision in classification of pregnant individuals with APS
- Updated criteria should not be used as diagnostic criteria in routine clinical practice
- Classification criteria are developed for research purposes, not for diagnosing patients
Original publication
Diagnostic, research, and real-life effect of the 2023 EULAR−ACR classification criteria for antiphospholipid syndrome. Lancet Rheumatol. Published 8 March 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →